Intervention not reported
It is very uncertain whether the intervention changes all‐cause mortality or liver‐related morbidity (very low certainty).
- RR 0.9 [0.38, 2.17]32 studies · 4617 participantsVery low
It is very uncertain whether the intervention changes all‐cause mortality or liver‐related morbidity (very low certainty).
The intervention showed no clear difference in adverse events (moderate certainty).
The intervention showed no clear difference in failure of end of treatment virological response Absence of… (moderate certainty).
The intervention showed no clear difference in failure of sustained virological response Absence of clearance of… (moderate certainty).
The intervention may leads to lower failure of normalisation of ALT at end of treatment (low certainty).
The intervention showed no clear difference in failure of normalisation of ALT at end of (low certainty).
T‐cell antibody induction showed no clear difference in mortality Mortality at latest compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in graft loss Graft loss (including death with a functioning graft) at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in acute rejection Number of participants who experienced at least 1… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in infection Number of participants who experienced at least 1 episode… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower cytomegalovirus infection Number of participants who experienced at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in hepatitis C recurrence Number of participants diagnosed with… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in malignancy Number of participants diagnosed with a malignancy compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower diabetes mellitus Number of participants with new‐onset diabetes… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower mortality Mortality at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction may leads to lower graft loss including death Graft loss including death at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction probably leads to lower acute rejection Number of participants who experienced at least 1… compared with placebo/no intervention (moderate certainty).